Suppr超能文献

下肢原发性骨肉瘤的保肢手术:人工关节置换重建的长期后果

Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions.

作者信息

Ham S J, Schraffordt Koops H, Veth R P, van Horn J R, Molenaar W M, Hoekstra H J

机构信息

Department of Surgical Oncology, Orthopaedics, Groningen University Hospital, The Netherlands.

出版信息

Ann Surg Oncol. 1998 Jul-Aug;5(5):423-36. doi: 10.1007/BF02303861.

Abstract

BACKGROUND

Adjuvant chemotherapy and endoprosthetic replacement for bone sarcomas of the lower extremity is well established. The specific long-term consequences of these endoprosthetic reconstructions for the patient's affected limb are unknown.

METHOD

The oncologic results and the survival of the endoprostheses were reviewed in 32 patients with primary bone sarcoma of the femur or proximal tibia. There were 26 high-grade sarcomas, and 6 low-grade sarcomas. A proximal femoral endoprosthesis was used for reconstruction in 4 patients, a total or push-through femoral endoprosthesis in 11 patients, a distal femoral endoprosthesis in 15 patients, and a proximal tibial endoprosthesis in two patients.

RESULTS

Median survival was 10 years (range, 1.1 to 18.9 years) for patients with high-grade sarcoma, and 8.1 years (range, 7.1 to 10 years) for patients with low-grade sarcomas. Distant metastases developed in seven patients (22%), all with stage IIB sarcoma, with concomitant local recurrence in 3 patients (9%). Five-year overall and disease-free survival rates for high-grade sarcomas were 81% and 73%, respectively. The overall endoprosthetic survival rate was 87% at 5 years, 80% at 10 years, and 56% at 15 years. Median follow-up of the original endoprostheses was 8.3 years (range, 0.6 to 18.7 years). Endoprosthesis-related complications occurred in 13 patients (41%); most complications were mechanical failures. The highest complication rate was found in distal femoral replacements (60%); amputation was necessary in both patients treated with a proximal tibial endoprosthesis. Five endoprostheses (16%) were revised. An amputation of the involved limb was performed in four patients (13%): in two patients because of local recurrence and in the other two patients because of infection. For patients alive at follow-up, the median functional Enneking evaluation score was 22 points (range, 12 to 28 points), with the highest functional scores in patients with a distal femoral endoprosthesis, and the lowest functional scores in patients with total or push-through femoral replacements.

CONCLUSION

Endoprosthetic reconstructions gave satisfying functional results in most patients after long-term survival. However, the proximal tibial and distal femoral endoprosthesis are particularly at risk for long-term endoprosthetic complications requiring additional surgical procedures.

摘要

背景

辅助化疗和下肢骨肉瘤的人工关节置换术已得到广泛应用。这些人工关节重建对患者患肢的具体长期影响尚不清楚。

方法

回顾性分析32例股骨或胫骨近端原发性骨肉瘤患者的肿瘤学结果及人工关节的生存率。其中高级别肉瘤26例,低级别肉瘤6例。4例患者采用股骨近端人工关节重建,11例患者采用全股骨或贯通式股骨人工关节,15例患者采用股骨远端人工关节,2例患者采用胫骨近端人工关节。

结果

高级别肉瘤患者的中位生存期为10年(范围1.1至18.9年),低级别肉瘤患者的中位生存期为8.1年(范围7.1至10年)。7例患者(22%)发生远处转移,均为IIB期肉瘤,3例患者(9%)同时发生局部复发。高级别肉瘤患者的5年总生存率和无病生存率分别为81%和73%。人工关节的总生存率在5年时为87%,10年时为80%,15年时为56%。原始人工关节的中位随访时间为8.3年(范围0.6至18.7年)。13例患者(41%)发生人工关节相关并发症;大多数并发症为机械故障。股骨远端置换的并发症发生率最高(60%);2例接受胫骨近端人工关节治疗的患者均需要截肢。5例人工关节(16%)进行了翻修。4例患者(13%)接受了患肢截肢:2例因局部复发,另外2例因感染。对于随访时存活的患者,中位功能Enneking评分为22分(范围12至28分),股骨远端人工关节患者的功能评分最高,全股骨或贯通式股骨置换患者的功能评分最低。

结论

人工关节重建在大多数长期存活的患者中取得了满意的功能结果。然而,胫骨近端和股骨远端人工关节尤其容易出现需要额外手术的长期人工关节并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验